• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Acyclo-V
    / CTS


    Active Ingredient
    Aciclovir 200 mg, 400 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 200 mg

    partial basket chart 59112 1903

    Tablets

    30 X 400 mg

    partial basket chart 59113 1904

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    Treatment of herpes simplex, infections of skin and mucous membranes including initial and recurrent genital herpes. Suppression of recurrent herpes simplex infections. Prophylaxis of herpes simplex infections in immune compromised patients. Treatment of herpes zoster infections. For the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications these groups are as follows: Patients over 13 years of age who are otherwise healthy. Children over 12 months of age with chronic cutaneous or pulmonary condition, or receiving long term salicylate therapy. Children receiving short or intermittent courses of aerosolized corticosteroids. The drug should not be taken if more than 24 hours have passed from the onset of a typical chickenpox rash.


    Contra-Indications

    Hypersensitivity to acyclovir or valaciclovir.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Manufacturer
    CTS Chemical Industries Ltd

    סרגל נגישות

    CLOSE